DCT Board Gives Concept Approval to “National Drug Discovery Groups,” Suggests Four At $1 Million Each
In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982
Tim Lee Carter Named Chairman Of NCAB; Five Others Appointed
CCOP RFA Due In Mid-July; DCT Board Gives Its Concept Approval
News Council Says Post Series “Flawed By Sensationalism”
DCCP Board Okays Noncompetitive Procurements
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- ASCO & The Conquer Cancer Foundation announce merit awards
- CBER Director Vinay Prasad dared to “say no to drugs”
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists”









